Insider Stock Trading History of Quisel John D


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Quisel John D since year 2005. The trader's CIK number is 1586788. At the time of this reporting, Quisel John D is the SVP, Corp. Dev., GC & Sec. of Acceleron Pharma Inc . (stock ticker symbol XLRN). See this page for all insider trading activities at Acceleron Pharma Inc .


Stock purchases, sales, and option exercises reported by insider Quisel John D since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-01-02 XLRN Acceleron Pharma Inc Sale 4,333 42.42 183,805
2017-09-12 XLRN Acceleron Pharma Inc Sale 5,105 38.83 198,227
2017-09-13 XLRN Acceleron Pharma Inc Sale 8 38.03 304
2017-01-04 XLRN Acceleron Pharma Inc Sale 1,700 27.00 45,891
2016-09-21 XLRN Acceleron Pharma Inc Sale 45,952 38.05 1,748,473
2016-09-21 XLRN Acceleron Pharma Inc Option Ex 25,952 11.70 303,716
2016-09-12 XLRN Acceleron Pharma Inc Sale 21,438 32.14 689,017
2016-09-12 XLRN Acceleron Pharma Inc Option Ex 16,438 5.43 89,209
2015-09-14 XLRN Acceleron Pharma Inc Option Ex 5,500 3.88 21,340
2015-09-14 XLRN Acceleron Pharma Inc Sale 5,500 33.62 184,910
2015-08-14 XLRN Acceleron Pharma Inc Option Ex 5,500 4.88 26,840
2015-08-14 XLRN Acceleron Pharma Inc Sale 5,500 30.98 170,390
2015-07-30 XLRN Acceleron Pharma Inc Option Ex 13,422 5.28 70,868
2015-07-14 XLRN Acceleron Pharma Inc Option Ex 5,500 5.88 32,340
2015-07-14 XLRN Acceleron Pharma Inc Sale 5,500 30.00 165,000
2015-06-17 XLRN Acceleron Pharma Inc Option Ex 7,701 3.88 29,879
2015-06-15 XLRN Acceleron Pharma Inc Option Ex 5,500 5.88 32,340
2015-06-15 XLRN Acceleron Pharma Inc Sale 5,500 31.13 171,215
2015-05-14 XLRN Acceleron Pharma Inc Sale 5,500 31.43 172,892
2015-05-14 XLRN Acceleron Pharma Inc Option Ex 5,500 5.88 32,340
2015-03-13 XLRN Acceleron Pharma Inc Option Ex 4,000 5.08 20,320
2015-03-13 XLRN Acceleron Pharma Inc Sale 4,000 41.66 166,660
2015-03-16 XLRN Acceleron Pharma Inc Option Ex 5,500 5.88 32,340
2015-03-16 XLRN Acceleron Pharma Inc Sale 5,500 40.94 225,142
2015-03-04 XLRN Acceleron Pharma Inc Option Ex 9,500 4.25 40,403
2015-03-04 XLRN Acceleron Pharma Inc Sale 9,500 41.40 393,281
2015-01-14 XLRN Acceleron Pharma Inc Option Ex 9,500 3.79 36,024
2015-01-14 XLRN Acceleron Pharma Inc Sale 9,500 40.20 381,871
2014-12-17 XLRN Acceleron Pharma Inc Option Ex 15,000 3.88 58,200
2014-12-12 XLRN Acceleron Pharma Inc Option Ex 4,000 .92 3,680
2014-12-12 XLRN Acceleron Pharma Inc Sale 4,000 41.22 164,880
2014-11-14 XLRN Acceleron Pharma Inc Sale 4,000 33.98 135,920
2014-11-14 XLRN Acceleron Pharma Inc Option Ex 4,000 .92 3,680
2014-11-12 XLRN Acceleron Pharma Inc Option Ex 5,000 6.50 32,500
2014-11-12 XLRN Acceleron Pharma Inc Sale 5,000 33.01 165,050
2014-10-14 XLRN Acceleron Pharma Inc Sale 4,000 29.02 116,080
2014-10-14 XLRN Acceleron Pharma Inc Option Ex 4,000 .92 3,680
2014-09-30 XLRN Acceleron Pharma Inc Sale 7,000 30.01 210,070
2014-09-30 XLRN Acceleron Pharma Inc Option Ex 7,000 6.20 43,400
2014-09-12 XLRN Acceleron Pharma Inc Option Ex 2,000 .92 1,840
2014-09-12 XLRN Acceleron Pharma Inc Sale 2,000 25.43 50,860
2014-08-14 XLRN Acceleron Pharma Inc Option Ex 13,000 3.83 49,751
2014-08-14 XLRN Acceleron Pharma Inc Sale 13,000 29.91 388,765
2014-07-14 XLRN Acceleron Pharma Inc Sale 5,000 29.51 147,550
2014-07-14 XLRN Acceleron Pharma Inc Option Ex 5,000 3.10 15,500
2014-06-13 XLRN Acceleron Pharma Inc Option Ex 9,000 3.36 30,240
2014-06-13 XLRN Acceleron Pharma Inc Sale 9,000 33.99 305,955
2014-05-19 XLRN Acceleron Pharma Inc Option Ex 9,000 2.40 21,600
2014-05-19 XLRN Acceleron Pharma Inc Sale 9,000 31.66 284,940
2014-04-22 XLRN Acceleron Pharma Inc Option Ex 2,000 .92 1,840
2014-04-22 XLRN Acceleron Pharma Inc Sale 2,000 35.94 71,880

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Quisel John D (SVP, Corp. Dev., GC & Sec. of Acceleron Pharma Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.